Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Calancardin B may help reduce inflammation in immune cells.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Somatostatin may help protect hair follicles from immune attacks.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

ILC1-like cells can independently cause alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

Imatinib can cause hair loss due to lichen planopilaris.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Immunoadsorption successfully treated a man's resistant polymyositis.

Patients with skin immune diseases need better education on UV protection to improve compliance.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.